BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 19111795)

  • 1. 2007 Annual Meeting of the Society of Urologic Oncology and the Society of Basic Urologic Research: Introduction.
    Mohler JL
    Urol Oncol; 2009; 27(1):34-5. PubMed ID: 19111795
    [No Abstract]   [Full Text] [Related]  

  • 2. SUO/SBUR 2007 annual meeting proceedings: overview.
    Evans CP
    Urol Oncol; 2009; 27(1):33. PubMed ID: 19111794
    [No Abstract]   [Full Text] [Related]  

  • 3. Highlights of the 2008 SUO/SBUR annual meeting: current controversies in urologic oncology.
    Kibel AS
    Urol Oncol; 2009; 27(3):293-4. PubMed ID: 19414114
    [No Abstract]   [Full Text] [Related]  

  • 4. The changing landscape of urologic oncology: initiating systemic therapies, interventional skills, and clinical trials. Introduction.
    Lin DW; Shore ND
    Urol Oncol; 2012; 30(4 Suppl):S1. PubMed ID: 22795074
    [No Abstract]   [Full Text] [Related]  

  • 5. The future of quality in urologic oncology: evaluating the horizon of surgical standards.
    Hampson LA; Brajtbord JS; Meng MV
    Urol Oncol; 2014 Aug; 32(6):735-40. PubMed ID: 25232559
    [No Abstract]   [Full Text] [Related]  

  • 6. Guest editorial: robotic techniques in urologic oncology.
    Kane CJ; Kader AK
    World J Urol; 2013 Jun; 31(3):429. PubMed ID: 23595604
    [No Abstract]   [Full Text] [Related]  

  • 7. Food and Drug Administration process for development and approval of drugs and radiopharmaceuticals: treatments in urologic oncology.
    Ning YM; Maher VE
    Urol Oncol; 2015 Mar; 33(3):137-42. PubMed ID: 25613202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Active studies of the Working Association for Urological Oncology (AUO) in 2006].
    Rexer H
    Urologe A; 2006 Feb; 45(2):229-40. PubMed ID: 16440204
    [No Abstract]   [Full Text] [Related]  

  • 9. The history and future of the Urologic Oncology Study Group (UOSG) of the Japan Clinical Oncology Group (JCOG).
    Tobisu K
    Jpn J Clin Oncol; 2012 May; 42(5):363-7. PubMed ID: 22450928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urological oncology in Europe. Research highlights from the XVIIth congress of the European Association of Urology, Birmingham, UK, February 23-26, 2002.
    Thompson E
    Drugs Today (Barc); 2002 Apr; 38(4):221-34. PubMed ID: 12532191
    [No Abstract]   [Full Text] [Related]  

  • 11. Artificial Intelligence - Changing the Field of Prostate Cancer?
    Rohan P; O'Reilly MK; Nason GJ
    Ir Med J; 2020 Mar; 113(3):45. PubMed ID: 32815705
    [No Abstract]   [Full Text] [Related]  

  • 12. Systemic therapy and the urologic oncologist: a unique opportunity for the specialty to provide comprehensive care that ultimately benefits the patient.
    Penson DF; Lange PH
    Urol Oncol; 2012; 30(4 Suppl):S2-4. PubMed ID: 22795076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hybrid of basic science and clinical training for the urologic oncologist: Necessity or waste?
    Olumi AF; Dewolf WC
    Urol Oncol; 2009; 27(2):205-7. PubMed ID: 19285235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artificial intelligence in urological oncology: An update and future applications.
    Brodie A; Dai N; Teoh JY; Decaestecker K; Dasgupta P; Vasdev N
    Urol Oncol; 2021 Jul; 39(7):379-399. PubMed ID: 34024704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Third annual meeting of the Society of Urologic Oncology: Bethesda, Maryland, December 13-14, 2002.
    Lee D
    Clin Prostate Cancer; 2003 Mar; 1(4):203-6. PubMed ID: 15040876
    [No Abstract]   [Full Text] [Related]  

  • 16. Do high-volume hospitals and surgeons provide better care in urologic oncology?
    Eastham JA
    Urol Oncol; 2009; 27(4):417-21. PubMed ID: 19573772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A 2021 inventory in oncology news].
    Bay JO; Bouleuc C; Firmin N; Gandemer V; Magne N; Orbach D; Penel N; Rodrigues M; Thiery-Vuillemin A; Wislez M; L'Allemain G; Sabatier R; Robert J;
    Bull Cancer; 2022 Jan; 109(1):8-19. PubMed ID: 34980367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artificial neural networks for decision-making in urologic oncology.
    Anagnostou T; Remzi M; Lykourinas M; Djavan B
    Eur Urol; 2003 Jun; 43(6):596-603. PubMed ID: 12767358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A window into new drug development for urologic oncology. Part I: How bench-to-bedside research can result in approval.
    Haas GP; Scher HI
    Urol Oncol; 2015 Mar; 33(3):115. PubMed ID: 25620153
    [No Abstract]   [Full Text] [Related]  

  • 20. In memoriam: a curious and careful gentleman--John P. Donohue, M.D.
    Koch M; Nichols C
    Urol Oncol; 2009; 27(1):1-2. PubMed ID: 19111793
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.